Lindsey Rolfe's Insider Trades & SAST Disclosures

Lindsey Rolfe's most recent trade in CERo Therapeutics Holdings Inc. was a trade of 9,326 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 30, 2025.

Share

Note

This is a custom search result for pattern Lindsey Rolfe.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
CERo Therapeutics Holdings...	Lindsey Rolfe	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 May 2025	9,326	9,326	-		-	Stock Option (Right to Buy)
CERo Therapeutics Holdings...	Lindsey Rolfe	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Mar 2025	17,923	17,923	-		-	Stock Option (Right to Buy)
CERo Therapeutics Holdings...	Lindsey Rolfe	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Feb 2025	127,500	255,000	-		-	Stock Option (Right to Buy)
CERo Therapeutics Holdings...	Lindsey Rolfe	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Dec 2024	127,500	127,500	-		-	Stock Option (Right to Buy)
CERo Therapeutics Holdings...	Lindsey Rolfe	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Mar 2024	112,500	112,500	-		-	Stock Option (Right to Buy)
Atreca Inc - Ordinary Shar... 52 week high	Lindsey Rolfe	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2023	12,000	12,000	-		-	Stock Option (right to buy)
Atreca Inc - Ordinary Shar... 52 week high	Lindsey Rolfe	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2022	12,000	12,000	-		-	Stock Option (right to buy)
Atreca Inc - Ordinary Shar... 52 week high	Lindsey Rolfe	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2021	12,000	12,000	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades